COVID-19 Vaccine (Covishield)

Covishield (AZD1222/ChAdOx1) is a viral vector vaccine developed by AstraZeneca and Oxford University, manufactured by Serum Institute of India. It was the most widely administered COVID-19 vaccine in India.

The COVID-19 Vaccine (Covishield) is recommended for 18 years and above. It falls under the COVID-19 vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The COVID-19 Vaccine (Covishield) has an efficacy of 76% against symptomatic COVID-19; 100% against severe disease and hospitalization. This means it provides significant protection against COVID-19 (SARS-CoV-2 infection) and Severe COVID-19. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Pain at injection site; fatigue; headache; myalgia. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The COVID-19 Vaccine (Covishield) should be avoided by: History of VITT; severe allergy to vaccine components; active COVID-19.. Always inform your healthcare provider of your full medical history before vaccination.

The COVID-19 Vaccine (Covishield) typically costs Free at government centres; ₹600–₹780 private in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.